Skip to main content

KNSA

Kiniksa Pharmaceuticals International, plc

Company with tickers: KNSA

CIK
1730430
CUSIP
G52694109
Shares Outstanding
46,303,276
13F Activity (30d)
172 filings 167 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 229
Total Value: $2,238,723,216
Total Shares: 46,494,774
Showing 1–100 of 234 holdings by value · page 1 of 3

Institutional Ownership Trend

8 quarters

Holder Concentration

Across 229 13F filers · Δ vs Dec 31, 2025
Top Holder
14.7%
Jun 2024 → Mar 2026 · range 7.5% – 14.7%
+7.2 pts
Top 5
37.5%
Jun 2024 → Mar 2026 · range 29.7% – 45.7%
+7.8 pts
Top 10
49.6%
Jun 2024 → Mar 2026 · range 45.5% – 67.3%
+4.1 pts
HHI
434
Jun 2024 → Mar 2026 · range 296 – 576
Broadly held +138

Quarterly Activity

vs Dec 31, 2025
New
41
Increased
75
Decreased
86
Sold Out
36
Unchanged
27
Holder count: +5
Institutional value: +21.7%
Shares held: +4.3%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 234
Export CSV
Holder Value (USD) % of 13F Shares Open